AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

180.370

-0.130-0.07%

Volume:773.61K

Turnover:139.76M

Market Cap:87.51B

PE:20.53

High:182.540

Open:180.900

Low:179.970

Close:180.500

52wk High:272.649

52wk Low:168.000

Shares:485.15M

Float Shares:483.95M

Volume Ratio:0.78

T/O Rate:0.16%

Dividend:4.16

Dividend Rate:2.30%

EPS(TTM):8.784

EPS(LYR):8.784

ROE:15.37%

ROA:6.63%

PB:3.18

PE(LYR):20.53

Loading ...

Overview Company News Filings

Seqirus Spin-off Pause and Flu Demand Concerns Could Be A Game Changer For CSL (ASX:CSL)

Simply Wall St.

DIARY-Australia, New Zealand corporate earnings week ahead

Haemonetics meldet Free Cash Flow im dritten Quartal 2026 von 165,42 Mio. USD mit Anstieg um 233 Prozent

Assessing CSL’s (ASX:CSL) Valuation As Results And Dividend Expectations Confront Recent Growth And Regulatory Headwinds

Simply Wall St.

Cochin Shipyard Limited Invites Global Expressions of Interest for Empanelment of Territorial Representatives

Does CSL (ASX:CSL) Offer Value After A 34% One Year Share Price Fall

Simply Wall St.

William Blair Initiates Coverage on Carlisle Companies With Market Perform

MT Newswires Live

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

How CSL’s ADR Switch and Plasma Pressures At CSL (ASX:CSL) Has Changed Its Investment Story

Simply Wall St.

BUZZ-Jefferies sees low risk of earnings impact for CSL from potential US regulatory review

Assessing CSL (ASX:CSL) Valuation As Half Year Results And Seqirus Uncertainty Approach

Simply Wall St.

The Bull Case For Carlisle Companies (CSL) Could Change Following Its Vision 2030 Acquisition Drive – Learn Why

Simply Wall St.

How Investors May Respond To CSL (ASX:CSL) After RBC Upgrade Amid Seqirus Spin-Off Pause

Simply Wall St.

Shenzhen CSL Vacuum Science and Technology Prices IPO, Seeks Up to 1.56 Billion Yuan in Proceeds

MT Newswires Live

Assessing CSL (ASX:CSL) Valuation After RBC Capital Upgrade And Recent Share Price Selloff

Simply Wall St.

FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms

Australian Healthcare Stocks Look Primed for M&A -- Market Talk

CEO Transitions Create Risks for Australian Healthcare Investors -- Market Talk

A Look At Carlisle Companies (CSL) Valuation After Recent Share Price Strength Rebuilds Longer Term Momentum

Simply Wall St.

A Look At CSL (ASX:CSL) Valuation As Investors Await Plasma And Vaccine Update In February Results

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CSL.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":180.37,"timestamp":1770613882927,"preClose":180.5,"halted":0,"volume":773607,"delay":0,"changeRate":-0.0007202216066481742,"nameEN":"CSL LIMITED","floatShares":483950454,"shares":485151394,"eps":8.783604410309703,"marketStatus":"Post Close","change":-0.13,"latestTime":"02-09 16:13:49 AEDT","open":180.9,"high":182.54,"low":179.97,"amount":139760360,"amplitude":0.014238,"askPrice":180.41,"askSize":560,"bidPrice":180.32,"bidSize":1180,"shortable":3,"etf":0,"ttmEps":8.783604410309703,"tradingStatus":3,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770678000000},"marketStatusCode":15,"adr":0,"exchange":"ASX","adjPreClose":180.5,"dividendRate":0.023081,"openAndCloseTimeList":[[1770591600000,1770613200000]],"volumeRatio":0.780627,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":483950454,"roa":"6.63%","roe":"15.37%","lyrEps":8.783604,"volumeRatio":0.780627,"shares":485151394,"dividePrice":4.156909,"high":182.54,"amplitude":0.014238,"preClose":180.5,"low":179.97,"week52Low":168,"pbRate":"3.18","psRate":"3.95","week52High":272.649,"institutionHeld":0,"latestPrice":180.37,"committee":0.356322,"eps":8.783604410309703,"divideRate":0.023047,"volume":773607,"delay":0,"ttmEps":8.783604410309703,"open":180.9,"prevYearClose":172.65,"prevWeekClose":180.5,"prevMonthClose":181.42,"prevQuarterClose":172.65,"fiveDayClose":177.08,"twentyDayClose":174.29,"sixtyDayClose":178.12,"earningDate":1770739200000,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":4,"dividendGrowthRate":0.11620984529927163,"fiveYearAvgDividendRate":0.013182154300910737},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"},{"date":"2025-08-19","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755561600000,"name":null,"time":"","dateTimestamp":1755525600000,"actualEps":null},{"date":"2025-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2025-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-09","payableDate":"2025-03-11","currency":"USD","dateTimestamp":1741525200000,"payDate":"2025-04-09"},{"date":"2025-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1739228400000,"name":null,"time":"","dateTimestamp":1739192400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609446795","title":"Seqirus Spin-off Pause and Flu Demand Concerns Could Be A Game Changer For CSL (ASX:CSL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609446795","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609446795?lang=en_us&edition=fundamental","pubTime":"2026-02-07 12:21","pubTimestamp":1770438096,"startTime":"0","endTime":"0","summary":"In recent weeks, CSL has been in focus as investors look back on its February 11 half-year results and interim dividend announcement, following earlier cuts to its fiscal 2026 growth outlook and a pause to the planned Seqirus vaccines spin-off after weaker US flu vaccination rates.\nAt the same time, CSL has faced regulatory scrutiny over Tavneos data in Europe and tougher competition for its Vifor iron products, sharpening attention on how well the group can balance growth ambitions with...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/seqirus-spin-off-pause-and-flu-demand-concerns-could-be-a-ga","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/seqirus-spin-off-pause-and-flu-demand-concerns-could-be-a-ga","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AI","BK4023","SGXZ23171101.USD","BK7501","BK7508","BK7511","BK4086","BK7067","BK4528","LU1169589451.USD","SG9999004303.SGD","BK4585","BK4551","BK4543","LU0728928796.USD","LU1169590202.USD","BK4588","BK4587","CSL","CSL.AU"],"gpt_icon":0},{"id":"2609653957","title":"DIARY-Australia, New Zealand corporate earnings week ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2609653957","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609653957?lang=en_us&edition=fundamental","pubTime":"2026-02-06 09:00","pubTimestamp":1770339600,"startTime":"0","endTime":"0","summary":"DIARY-Australia, New Zealand corporate earnings week aheadFeb 6 (Reuters) - Diary of Australia and New Zealand (.AXJO, .NZ50) corporate earnings for the week ahead AUSTRALIA & NEW ZEALAND EARNINGS Sta","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nL4N3Z11DW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IAG.AU","BK7508","TPW.AU","BK7107","JHX","BK7006","COH.AU","CSL.AU","BK7007","NST.AU","BK4011","S32.AU","BK7094","BK7067","BK7165","HDN.AU","BK7511","WBC.AU","BK7136","BK7095","BK7120","BK7501","BK7506","BK7507","SGH.AU","EVN.AU","AMP.AU","BK7031","BK7062","NCK.AU","BK7135","BK7005","BK4135","GQPIL","CIP.AU","ORG.AU","BK7034","GQG.AU","BK7119","BK7112","BK7049","ARF.AU","CBA.AU","PME.AU","AGL.AU","BK7162","BK7130","BK7099","BRG.AU","CLW.AU"],"gpt_icon":0},{"id":"2609837610","title":"Haemonetics meldet Free Cash Flow im dritten Quartal 2026 von 165,42 Mio. USD mit Anstieg um 233 Prozent","url":"https://stock-news.laohu8.com/highlight/detail?id=2609837610","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609837610?lang=en_us&edition=fundamental","pubTime":"2026-02-05 19:02","pubTimestamp":1770289358,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Haemonetics Corporation published the original content used to generate this news brief on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL5JhlcD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z6F94.USD","LU0205193047.USD","LU0106261612.USD","BK7508","BK7511","BK4198","IE00BLDYK493.USD","BK7501","BK7067","CSL.AU","HAE","IE0034390439.USD","IE00B64QTZ34.USD","LU1169589451.USD","LU1169590202.USD","LU0012050646.USD","LU0205194284.USD"],"gpt_icon":0},{"id":"2609434698","title":"Assessing CSL’s (ASX:CSL) Valuation As Results And Dividend Expectations Confront Recent Growth And Regulatory Headwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=2609434698","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609434698?lang=en_us&edition=fundamental","pubTime":"2026-02-05 07:47","pubTimestamp":1770248822,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is back in focus after its share price reacted to fresh anticipation around the upcoming half-year results and interim dividend, with recent guidance changes and regulatory reviews shaping expectations.\nSee our latest analysis for CSL.\nAt A$181.7, CSL’s recent 1 month share price return of 5.36% and 1 day gain of 2.02% suggest short term momentum is building again, although the 1 year total shareholder return of 31.46% decline shows longer term holders are still sitting on...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csls-asxcsl-valuation-as-results-and-dividend-expe","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csls-asxcsl-valuation-as-results-and-dividend-expe","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","BK7508","BK7511","BK7501","SGXZ23171101.USD","BK7067","CSL.AU","BK4086","LU0728928796.USD","LU1169589451.USD","CSL","LU1169590202.USD"],"gpt_icon":0},{"id":"2608085408","title":"Cochin Shipyard Limited Invites Global Expressions of Interest for Empanelment of Territorial Representatives","url":"https://stock-news.laohu8.com/highlight/detail?id=2608085408","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608085408?lang=en_us&edition=fundamental","pubTime":"2026-02-02 17:20","pubTimestamp":1770024000,"startTime":"0","endTime":"0","summary":"KOCHI, India, Feb. 2, 2026 /PRNewswire/ -- Cochin Shipyard Limited , a premier Government of India enterprise, has invited Expressions of Interest  from internationally reputed companies, firms, or agencies for empanelment as Territorial Representatives for ship repair and refit projects across key global markets.This initiative is part of CSL's strategic efforts to strengthen its global outreach and deliver world-class ship repair, refit, and conversion services to international customers. The empanelled Territorial Representatives will support CSL by leveraging local market intelligence, promoting its ship repair capabilities, and facilitating business development within their respective regions.Commenting on the initiative, a CSL spokesperson said that this empanelment initiative aligns with their long-term vision to enhance Cochin Shipyard's global footprint and provide customers worldwide with seamless access to CSL's ship repair and refit expertise","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/cochin-shipyard-limited-invites-global-expressions-of-interest-for-empanelment-of-territorial-representatives-302676101.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999004303.SGD","LU0728928796.USD","BK4086","BK4195","BK7511","BK7508","BK7067","CSL.AU","CSL","SGXZ23171101.USD","BK7501","LU1169589451.USD","TBNK","LU1169590202.USD","BK4211"],"gpt_icon":0},{"id":"2608077467","title":"Does CSL (ASX:CSL) Offer Value After A 34% One Year Share Price Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2608077467","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608077467?lang=en_us&edition=fundamental","pubTime":"2026-01-31 23:31","pubTimestamp":1769873511,"startTime":"0","endTime":"0","summary":"If you are wondering whether CSL is priced attractively right now, its recent share performance and current valuation profile raise some timely questions.\nCSL last closed at A$181.42, with returns of 1.0% over 7 days and 5.1% over 30 days, while the 1 year and 3 year returns of a 34.0% decline and 39.5% decline contrast with a 5.5% gain year to date.\nRecent coverage around CSL has focused on its position as a major Australian healthcare stock and ongoing interest from investors assessing how...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-offer-value-after-a-34-one-year-share-price","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/does-csl-asxcsl-offer-value-after-a-34-one-year-share-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SGXZ23171101.USD","BK7501","BK4086","BK7511","LU1169589451.USD","LU1169590202.USD","LU0728928796.USD","CSL","CSL.AU","DCF","BK7508","BK7067","SG9999004303.SGD"],"gpt_icon":0},{"id":"2607010424","title":"William Blair Initiates Coverage on Carlisle Companies With Market Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2607010424","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607010424?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:20","pubTimestamp":1769775602,"startTime":"0","endTime":"0","summary":"Carlisle Companies (CSL) has an average rating of overweight and mean price target of $371.25, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1169589451.USD","BK7067","LU1169590202.USD","BK4086","BK7501","CSL","BK7511","BK7508","LU0728928796.USD","CSL.AU","SGXZ23171101.USD","SG9999004303.SGD"],"gpt_icon":0},{"id":"2607801702","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2607801702","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607801702?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:07","pubTimestamp":1769774827,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsChanges dateline, adds Eli Lilly details in paragraph 11. Jan 30  - Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers a 100% tariff on imported branded and patented medicines.Although enforcement is delayed for companies investing in U.S. manufacturing, the policy has already prompted fast-tracked projects, price cuts and direct-to-consumer sales.Pfizer and AstraZeneca secured multi-year tariff exemptions through pricing deals and commitments to the new TrumpRx.gov platform. Eli Lilly, Johnson & Johnson and Merck have pledged billions to expand U.S. operations to avoid penalties.Here's what drugmakers are doing to mitigate supply-chain risks and reassure investors:Pfizer PFE.N Pfizer reached a deal with President Donald Trump on September 30 to invest $70 billion in research and development and domestic manufacturing, and received a three-year grac","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260130:nL4N3YV11K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2063271972.USD","IE00BKPKM429.USD","LU0963555726.SGD","LU1221951129.SGD","LU1732799900.SGD","IE00BFSS8Q28.SGD","BK4585","LU0289739699.SGD","LU0471298694.HKD","LU0640478417.SGD","LU2106854487.HKD","SG9999015945.SGD","LU0211326839.USD","LU2089984988.USD","LU1804176565.USD","LU2750360641.GBP","LU2168564222.USD","LU0211331839.USD","BK4533","LU0786609619.USD","LU0385154629.USD","BK5011","LU1880407215.USD","IE00B1BXHZ80.USD","LU0965508806.USD","IE00BLSP4452.SGD","SG9999014567.USD","LU2430703095.HKD","SG9999014914.USD","SG9999014575.USD","IE00BJJMRZ35.SGD","LU0976567544.SGD","LU1032466523.USD","LU0784383803.USD","SG9999015986.USD","IE00BK4W5L77.USD","LU1989772840.SGD","LU0210536198.USD","LU0985320562.USD","LU2237443978.SGD","LU0106261372.USD","LU1585245621.USD","LU2347655156.SGD","LU2271345857.HKD","IE0004445015.USD","LU1127390331.HKD","LU0306807586.USD","LU0882574139.USD","LU0320765059.SGD","LU1301847155.USD","LU1074936037.SGD","LU2456880835.USD","LU0823399737.USD","LU1037948897.HKD","LU0960981461.USD","LU0861579265.USD","LU0234570918.USD","LU0256863902.USD","LU1069344957.HKD","LU0820561909.HKD","BK7508","LU0061475181.USD","LU0553294199.USD","LU1718418525.SGD","LU0857590862.USD","LU1035775433.USD","IE00B19Z3B42.SGD","LU2417539215.USD","LU0128525929.USD","LU0130102774.USD","IE00BFXG1179.USD","LU1267930730.SGD","LU2360106947.USD","LU0661504455.SGD","LU1066051811.HKD","LU0321505439.SGD","LU2471134523.USD","SGXZ81514606.USD","LU0345770308.USD","IE00BJLML261.HKD","IE00BKVL7J92.USD","LU1814569148.SGD","LU2491049909.HKD","LU1548497426.USD","LU0029864427.USD","IE00BSNM7G36.USD","LU1023059063.AUD","LU2279689827.SGD","IE00B19Z9P08.USD","GSK","LU0203201768.USD","LU1221951046.USD","LU1267930490.SGD","LU1487256676.USD","LU2750360997.AUD","LU1868836914.USD","BK4559","IE0002270589.USD","IE00BK4W5M84.HKD","RHHBY","LU0432979614.USD","LU1066051225.USD","IE00BLSP4239.USD","LU0225284248.USD","LU1261432733.SGD","LU1093756325.SGD","IE00B7SZLL34.SGD","BK4566","LU1934455277.USD","LU0096364046.USD","LU0109394709.USD","LU2237443465.HKD","LU1481599808.USD","LU1061106388.HKD","LU1868836757.USD","LU2552382058.USD","LU0795875169.SGD","LU0203347892.USD","LU0757432116.USD","LU2091194634.USD","SG9999011175.SGD","LU2089284900.SGD","LU0323591593.USD","BK4568","LU0787776722.HKD","LU1170363599.USD","IE00B7KXQ091.USD","LU0058720904.USD","LU0211328371.USD","LU0122379950.USD","LU2168563687.JPY","LU1244550494.USD","LU2112291526.USD","LU1983299246.USD","LU2237443549.SGD","LU0077335932.USD","BK4588","BK4578","LU2505996509.AUD","LU1104425308.USD","LU0320765992.SGD","LU0345770993.USD","LU1934455863.HKD","LU2552382132.HKD","LU2552382215.SGD","LU1267930813.SGD","IE00BWXC8680.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0868494617.USD","SGXZ31699556.SGD","LU1037948541.HKD","LU0526926950.USD","LU1244550221.USD","LU1019632923.USD","LU0965509101.SGD","LU0689472784.USD","IE00B19Z3581.USD","LU1481600234.SGD","IE00BVYPNV92.GBP","LU2491050154.USD","LU1051770623.HKD","LU0471298777.SGD","LU2471134796.USD","LU0353189763.USD","IE00B1XK9C88.USD","LU1989772923.USD","LU1674673428.USD","LU2242646821.SGD","IE00BGHQF631.EUR","BK4007","LU1941712264.USD","SG9999018865.SGD","LU0289739343.SGD","LU0225283273.USD","LU1712237335.SGD","SG9999015978.USD","IE00BJT1NW94.SGD","LU0965509283.SGD","LU1917777945.USD","BK4550","LU1720051108.HKD","IE00BVYPNW00.USD","LU1059921491.USD","BK4139","LU0345769128.USD","SG9999013999.USD","BK4532","LU0417517546.SGD","SGXZ99366536.SGD","LU1674673691.USD","LU1003077747.HKD","LU0011850046.USD","LU1496350171.SGD","BK4599","LU2264538146.SGD","LU1323610961.USD","LU2293690249.USD","SG9999014880.SGD","LU1064927863.SGD","LU0965509010.AUD","IE00BKPKM643.USD","LU0211326755.USD","LU0889565916.HKD","IE00BBT3K403.USD","IE00BJJMRY28.SGD","LU0648001328.SGD","LU2746668974.SGD","LU0310799852.SGD","LU0477156953.USD","LU1914381329.SGD","GB00BDT5M118.USD","LU1066053197.SGD","LU2168564149.EUR","LU2361045086.USD","LU0306806265.USD","LU2023251221.USD","BK4592","LU0203345920.USD","LU0265550946.USD","LU2242652126.USD","LU0943347566.SGD","IE0034235188.USD","LU1720051017.SGD","IE00B3T34201.USD","BK7511","SG9999018857.SGD","LU0823434740.USD","JNJ","LU0640476718.USD","LU0985481810.HKD","IE00B4R5TH58.HKD","LU1162221912.USD","LU0354030438.USD","LU0097036916.USD","LU0795875086.SGD","LU2023250504.SGD","SG9999015952.SGD","IE00B19Z9Z06.USD","SGXZ51526630.SGD","LU0557290698.USD","IE00BFTCPJ56.SGD","LU2087625088.SGD","LU0708995401.HKD","LU1196500208.SGD","BIIB","LU2324357040.USD","LU1551013342.USD","LU0949170772.SGD","IE0004445239.USD","LU0047473722.SGD","LU0889566641.SGD","LU0820561818.USD","LU0683600562.USD","SG9999002232.USD","BK4504","LU1153584641.USD","LU0094547139.USD","LU2462157665.USD","LU0211327993.USD","LU2114397693.USD","LU1244550577.SGD","LU1894683348.USD","LU0964806797.USD","LU1267930573.SGD","LU0882574055.USD","LU0057025933.USD","LU1015430645.USD","LU0158827781.USD","SG9999001440.SGD","LU0069063385.USD","IE00BDGV0183.EUR","SG9999014898.SGD","IE0009355771.USD","IE00BKDWB100.SGD","SG9999001176.USD","CSL.AU","LU1974910355.USD","LU1732800096.USD","LU0320765646.SGD","AMGN","IE00BN29S564.USD","LU1003076772.USD","LU2125154935.USD","LU1153585028.USD","LU0823416689.USD","IE0005OL40V9.USD","LU0784384876.USD","LU1064131342.USD","LU2468319806.SGD","LU0466842654.USD","LU0496365809.HKD","LU0098860793.USD","GILD","LU0345777147.USD","AZN","LU1934455194.USD","NVS","LU0266013472.USD","LU2111349929.HKD","LU0310800965.SGD","LU1280957306.USD","SG9999015341.SGD","LU2360032135.SGD","LU2461242641.AUD","BK7501","LU2361044865.SGD","SG9999014906.USD","IE00BJJMRX11.SGD","LU1069347547.HKD","LU0972486137.USD","LU0109391861.USD","LU0130517989.USD","LU1988902786.USD","LU1868837300.USD","LU2361044949.HKD","LU1032955483.USD","SNY","SG9999017495.SGD","LU1116320901.HKD","LU0320765489.SGD","LU1778281490.HKD","LU2168564065.EUR","LLY","MRK","LU2293690082.USD","LU1935042991.SGD","IE000M9KFDE8.USD","IE00B2B36J28.USD","IE00B4JS1V06.HKD","LU1078025761.USD","LU2125154778.USD","LU2471134952.CNY","LU0225771236.USD","LU2129689605.HKD","LU1093756168.USD","LU2089283258.USD","LU0208291251.USD","LU1119994496.HKD","LU2236285917.USD","SGXZ57979304.SGD","04332","LU0827474353.SGD","LU1839511570.USD","IE0034235303.USD","BK4534","LU2168564495.EUR","LU2133065610.SGD","LU1989771016.USD","IE00BFSS7M15.SGD","LU2237443622.USD","SG9999001176.SGD","LU0708994859.HKD","LU0511384066.AUD","LU2430703178.SGD","SG9999002224.SGD","LU1267930227.SGD","LU0792757196.USD","LU0321505868.SGD","LU0128525689.USD","LU0289961442.SGD","LU0456855351.SGD","LU0198837287.USD","BK4516","LU1883839398.USD","LU0203202063.USD","LU0545039389.USD","PFE","LU2505996681.GBP","LU0047473722.EUR","LU1551013425.SGD","LU0472753341.HKD","LU0889565080.SGD","LU1116320737.USD","LU2430703251.USD","LU1496350502.SGD","LU0784385840.USD","LU0672654240.SGD","LU1880407132.USD","LU1430594728.SGD","LU0052756011.USD","LU1868837136.USD","LU0256863811.USD","SG9999014559.SGD","IE00BN8TJ469.HKD","LU0738911758.USD","LU0969580561.USD","LU1291159041.SGD","ABBV","LU0689626769.HKD","LU1623119135.USD","LU0316494557.USD","IE00B3PB1722.GBP","LU0354030511.USD","SG9999003800.SGD","LU2237443382.USD","LU2592432038.USD","BK4583","LU2023250843.SGD","LU2237443895.HKD","LU1894683264.USD","LU2129689431.USD","LU2357305700.SGD","LU0114720955.EUR","LU1066051498.USD","LU1084165304.USD","LU2471134879.HKD","LU0345769631.USD","LU1019634622.SGD","LU2491050071.SGD","LU1201861249.SGD","LU0070217475.USD","BK7067","LU1941712348.USD","LU0345777659.USD","LU0070302665.USD","LU0997586432.USD","03165","LU0353189680.USD","LU2108987350.USD","IE00B894F039.SGD","LU2539964713.USD","IE00B775H168.HKD","LU2265009873.SGD","LU0949170426.SGD","BK4581","LU1057294990.SGD","LU0784385170.HKD","LU1506573853.SGD","SG9999015358.SGD","IE0002141913.USD","LU0499090636.EUR","LU2028103732.USD","LU2746668461.USD","LU0238689110.USD","LU0158827948.USD","LU0310800379.SGD","LU2211815571.USD","LU1232071149.USD","LU0920840948.USD","LU2129689514.USD","LU0980610538.SGD","LU1035773651.USD","LU1571399168.USD","LU0171293334.USD","LU0957799991.USD","LU2602419157.SGD","LU0265550359.USD","LU0006306889.USD","LU0170899867.USD","SG9999014542.SGD","LU0912757837.SGD","LU0920783379.SGD","LU0124676726.USD","LU1366192091.USD","LU0079474960.USD","LU1868836591.USD","LU2896262040.SGD","LU1929549753.HKD","LU0234572021.USD","LU2237438978.USD","LU0575583348.USD","LU0823434583.USD","IE00B42XCP33.USD","LU1699723380.USD"],"gpt_icon":1},{"id":"2607046165","title":"How CSL’s ADR Switch and Plasma Pressures At CSL (ASX:CSL) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2607046165","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607046165?lang=en_us&edition=fundamental","pubTime":"2026-01-30 17:31","pubTimestamp":1769765485,"startTime":"0","endTime":"0","summary":"Deutsche Bank has been appointed as the successor depositary bank for CSL Limited’s sponsored American Depositary Receipt program, effective 27 January 2026, while investors also await the company’s half-year results and interim dividend announcement on 11 February.\nThis comes after CSL cut its profit forecast, postponed the planned Seqirus vaccine spin-off, and faced pressure from weaker U.S. flu vaccination rates and cost challenges in its plasma therapies business.\nWe’ll now examine how...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-csls-adr-switch-and-plasma-pressures-at-csl-asxcsl-has-c","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-csls-adr-switch-and-plasma-pressures-at-csl-asxcsl-has-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1169589451.USD","BK4086","SG9999004303.SGD","SWCH","SGXZ23171101.USD","BK4116","BK7501","CSL.AU","BK7511","LU0728928796.USD","LU1169590202.USD","LU1093756168.USD","BK7508","LU1093756325.SGD","CSL","BK7067","BK4513"],"gpt_icon":0},{"id":"2607747214","title":"BUZZ-Jefferies sees low risk of earnings impact for CSL from potential US regulatory review","url":"https://stock-news.laohu8.com/highlight/detail?id=2607747214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607747214?lang=en_us&edition=fundamental","pubTime":"2026-01-29 04:52","pubTimestamp":1769633577,"startTime":"0","endTime":"0","summary":"BUZZ-Jefferies sees low risk of earnings impact for CSL from potential US regulatory review** Jefferies expects minimal risk of meaningful earnings impact for CSL CSL.AX as various U.S. regulatory reviews including CMS programs are undertaken** Brokerage says there is ongoing lack of regulatory focus on plasma - key product for CSL - compared with other drug categories** Adds plasma industry looks \"rational\", with expansion in blood-collection centres, inventory and capacity in line with demand, providing further upside for CSL** Jefferies maintains \"buy\" call for CSL, price target of A$240** CSL fell 38.7% last year  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260128:nL4N3YT2G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","BK7508","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2607746337","title":"Assessing CSL (ASX:CSL) Valuation As Half Year Results And Seqirus Uncertainty Approach","url":"https://stock-news.laohu8.com/highlight/detail?id=2607746337","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607746337?lang=en_us&edition=fundamental","pubTime":"2026-01-28 21:29","pubTimestamp":1769606953,"startTime":"0","endTime":"0","summary":"Investors are eyeing CSL (ASX:CSL) ahead of its February 11 half year results, with last year's profit guidance downgrade, the delayed Seqirus spin off and weaker US flu vaccinations still shaping sentiment.\nSee our latest analysis for CSL.\nCSL shares recently saw a 1-day share price return of a 1.15% decline to A$180.19. However, the 7-day and 30-day share price returns of 2.32% and 3.83% suggest some near term momentum after a weak year, with a 1-year total shareholder return of a 33.75%...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csl-asxcsl-valuation-as-half-year-results-and-seqi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csl-asxcsl-valuation-as-half-year-results-and-seqi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7511","BK7067","CSL","LU1169589451.USD","BK7501","LU0728928796.USD","CSL.AU","SG9999004303.SGD","SGXZ23171101.USD","BK7508","BK4086","LU1169590202.USD"],"gpt_icon":0},{"id":"2606245946","title":"The Bull Case For Carlisle Companies (CSL) Could Change Following Its Vision 2030 Acquisition Drive – Learn Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2606245946","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606245946?lang=en_us&edition=fundamental","pubTime":"2026-01-26 19:16","pubTimestamp":1769426195,"startTime":"0","endTime":"0","summary":"Carlisle Companies has been advancing its Vision 2030 strategy, using acquisitions in metal systems, insulation, and recycled materials to expand its building solutions portfolio and support energy-efficient construction demand in recent years.\nAn interesting angle is how Carlisle’s focus on operational excellence and disciplined capital allocation under Vision 2030 connects product innovation directly with long-term shareholder returns.\nNext, we’ll examine how the Vision 2030 growth...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/the-bull-case-for-carlisle-companies-csl-could-change-follow","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/the-bull-case-for-carlisle-companies-csl-could-change-follow","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","CSL.AU","BK7511","LU1169589451.USD","CSL","SGXZ23171101.USD","BK7508","SG9999004303.SGD","LU0728928796.USD","LU1169590202.USD","BK7501","BK4086"],"gpt_icon":0},{"id":"2605168441","title":"How Investors May Respond To CSL (ASX:CSL) After RBC Upgrade Amid Seqirus Spin-Off Pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2605168441","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605168441?lang=en_us&edition=fundamental","pubTime":"2026-01-23 03:44","pubTimestamp":1769111058,"startTime":"0","endTime":"0","summary":"RBC Capital recently upgraded CSL to Outperform, arguing that the recent selloff and upcoming February half-year results create a compelling opportunity despite sector headwinds.\nThe shift in analyst stance comes as investors reassess CSL’s credibility after it cut its fiscal 2026 growth outlook and paused the planned Seqirus vaccines spin-off.\nNext, we’ll examine how this upgrade, set against weaker flu vaccine demand and Seqirus uncertainty, shapes CSL’s investment narrative.\nWe've found...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-investors-may-respond-to-csl-asxcsl-after-rbc-upgrade-am","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/how-investors-may-respond-to-csl-asxcsl-after-rbc-upgrade-am","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL.AU","ISBC","CSL"],"gpt_icon":0},{"id":"2605430614","title":"Shenzhen CSL Vacuum Science and Technology Prices IPO, Seeks Up to 1.56 Billion Yuan in Proceeds","url":"https://stock-news.laohu8.com/highlight/detail?id=2605430614","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605430614?lang=en_us&edition=fundamental","pubTime":"2026-01-22 09:29","pubTimestamp":1769045378,"startTime":"0","endTime":"0","summary":"Shenzhen CSL Vacuum Science and Technology  priced its initial public offering of shares on the Shanghai Stock Exchange at 92.18 yuan apiece, according to a Thursday bourse filing.The semiconductor equipment components manufacturer is looking to raise up to 1.56 billion yuan in proceeds from the offering of 16.9 million shares.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7501","BK7511","CSL.AU","CSL","BK7067","SGXZ23171101.USD","688785","LU0728928796.USD","LU1169589451.USD","LU1169590202.USD","BK4086","SG9999004303.SGD","BK7508"],"gpt_icon":0},{"id":"2605489670","title":"Assessing CSL (ASX:CSL) Valuation After RBC Capital Upgrade And Recent Share Price Selloff","url":"https://stock-news.laohu8.com/highlight/detail?id=2605489670","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605489670?lang=en_us&edition=fundamental","pubTime":"2026-01-21 18:28","pubTimestamp":1768991322,"startTime":"0","endTime":"0","summary":"RBC Capital’s upgrade of CSL (ASX:CSL) to Outperform after the recent selloff has refocused attention on the stock. Investor interest is building around February’s half year results and the upcoming interim dividend decision.\nSee our latest analysis for CSL.\nCSL’s recent selloff has left the share price at A$176.70, with a 90 day share price return of a 19.94% decline and a 1 year total shareholder return of a 34.10% decline, signalling weaker momentum despite the short term lift after the...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csl-asxcsl-valuation-after-rbc-capital-upgrade-and","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/assessing-csl-asxcsl-valuation-after-rbc-capital-upgrade-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL","CSL.AU"],"gpt_icon":0},{"id":"2605110440","title":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat looms","url":"https://stock-news.laohu8.com/highlight/detail?id=2605110440","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605110440?lang=en_us&edition=fundamental","pubTime":"2026-01-21 01:08","pubTimestamp":1768928883,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers rush to boost US presence as tariff threat loomsAdds details on Roche, Abbvie and CSL. Global drugmakers are ramping up U.S. manufacturing and stockpiling inventory as the Trump administration considers","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nL4N3YL1OM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0057025933.USD","LU1551013342.USD","LU0868494617.USD","LU1894683264.USD","IE00BJJMRZ35.SGD","LU0225284248.USD","BK4583","LU0061475181.USD","LU1934455863.HKD","IE00B42XCP33.USD","LU2491049909.HKD","LU1941712264.USD","BK4588","IE00BK4W5L77.USD","LU2063271972.USD","LU2168564495.EUR","SG9999013999.USD","LU0047473722.SGD","LU0792757196.USD","LU0943347566.SGD","BK4504","IE00BN29S564.USD","LU1201861249.SGD","LU1035773651.USD","IE00BVYPNW00.USD","LU1019634622.SGD","LU0289739343.SGD","IE00B1XK9C88.USD","LU1221951046.USD","LU2108987350.USD","LU1066051225.USD","LU0321505868.SGD","IE00BVYPNV92.GBP","LU0310799852.SGD","LU1074936037.SGD","LU1244550577.SGD","IE0034235303.USD","04332","LU2324357040.USD","LU0070302665.USD","LU0882574055.USD","LU1623119135.USD","SGXZ81514606.USD","IE00B19Z3581.USD","LU1989772840.SGD","BK4550","IE00BFTCPJ56.SGD","LU0211326839.USD","LU1064131342.USD","LU0234570918.USD","LU1366192091.USD","LU0345777147.USD","IE00BJJMRY28.SGD","IE00BFSS8Q28.SGD","LU1267930227.SGD","LU2505996509.AUD","IE0002270589.USD","SNY","LU1506573853.SGD","LU1116320901.HKD","LU2430703178.SGD","SG9999014914.USD","LU2293690082.USD","LU2430703251.USD","LU1868836591.USD","IE00BKDWB100.SGD","LU0472753341.HKD","SG9999014567.USD","LU1804176565.USD","SG9999015341.SGD","LU1032955483.USD","LU2357305700.SGD","LU0823416689.USD","LU0787776722.HKD","LU0211328371.USD","BK4592","LU0882574139.USD","GB00BDT5M118.USD","SG9999001440.SGD","LU0912757837.SGD","LU0130102774.USD","LU2491050071.SGD","SG9999014906.USD","LU2461242641.AUD","LU2750360641.GBP","LU1989772923.USD","LU1868836914.USD","LU0211326755.USD","LU0640478417.SGD","PFE","BK7508","LU0353189763.USD","LU0575583348.USD","LU0957799991.USD","LU0320765059.SGD","LU2505996681.GBP","LU0058720904.USD","LU2023250504.SGD","LU0256863902.USD","LU1153584641.USD","IE00B19Z3B42.SGD","LU1291159041.SGD","LU0345769631.USD","LU0889565916.HKD","IE00BBT3K403.USD","LU1267930813.SGD","SGXZ57979304.SGD","LU0965508806.USD","LU0820561818.USD","LU1983299246.USD","LU1059921491.USD","LU1267930490.SGD","LU0963555726.SGD","LU0689626769.HKD","LU1674673428.USD","LU0920783379.SGD","IE0004445015.USD","LU0047473722.EUR","LU1868837136.USD","LU1084165304.USD","LU2129689605.HKD","LU1003076772.USD","LU0997586432.USD","LU2471134952.CNY","IE00BJLML261.HKD","LU0385154629.USD","LU0683600562.USD","LU2471134879.HKD","LU0052756011.USD","LU0289739699.SGD","03165","LU0466842654.USD","LU2125154778.USD","LU2539964713.USD","LU0757432116.USD","LU1880407215.USD","LU0708994859.HKD","LU2236285917.USD","LU0029864427.USD","LU0965509010.AUD","LU0320765992.SGD","LU1153585028.USD","LU0823399737.USD","LU0069063385.USD","IE000M9KFDE8.USD","LU0795875086.SGD","BK4568","LU0861579265.USD","LU1674673691.USD","LU2089984988.USD","SG9999014575.USD","LU0198837287.USD","LU0289961442.SGD","LU1064927863.SGD","LU1196500208.SGD","IE0034235188.USD","LU1732800096.USD","LU1914381329.SGD","LU2237443549.SGD","BIIB","LU1571399168.USD","LU2468319806.SGD","IE00BKPKM429.USD","IE0002141913.USD","IE00B775H168.HKD","LU0070217475.USD","LU0128525689.USD","LU0238689110.USD","LU0320765646.SGD","IE0009355771.USD","BK4007","IE0005OL40V9.USD","LU0965509283.SGD","LU2462157665.USD","LU1301847155.USD","BK5011","LU2129689431.USD","LU2242652126.USD","LU0011850046.USD","RHHBY","LU0820561909.HKD","LU2023250843.SGD","LU2237443622.USD","LU0738911758.USD","LU0827474353.SGD","LU2264538146.SGD","LU2125154935.USD","LU0823434740.USD","LU2361044949.HKD","BK4533","LU0964806797.USD","LU0203201768.USD","LU1069347547.HKD","LU0920840948.USD","LU1066053197.SGD","LU2242646821.SGD","JNJ","BK7067","LU0097036916.USD","LU0109394709.USD","BK4581","LU0456855351.SGD","LU1935042991.SGD","LU1699723380.USD","LU1280957306.USD","BK4534","LU2129689514.USD","LU0545039389.USD","LU0106261372.USD","LU0122379950.USD","LU1323610961.USD","IE00B2B36J28.USD","LU1232071149.USD","LU1093756168.USD","LU0557290698.USD","LU0889565080.SGD","LU2087621335.USD","SG9999014542.SGD","LU0077335932.USD","IE00B19Z9Z06.USD","LU2347655156.SGD","LLY","LU0006306889.USD","LU0471298694.HKD","IE00BLSP4239.USD","IE00BWXC8680.SGD","LU0323591593.USD","SG9999014898.SGD","LU1814569148.SGD","LU1974910355.USD","LU2750360997.AUD","LU2592432038.USD","LU0354030438.USD","LU0949170426.SGD","LU1720051017.SGD","LU0353189680.USD","LU1267930730.SGD","IE00BK4W5M84.HKD","LU0417517546.SGD","LU0526926950.USD","LU0114720955.EUR","LU0496365809.HKD","LU1244550221.USD","LU1481599808.USD","LU2361044865.SGD","LU0345770308.USD","LU1929549753.HKD","SGXZ99366536.SGD","LU1868836757.USD","LU0985481810.HKD","LU1119994496.HKD","LU2552382215.SGD","LU1035775433.USD","CSL.AU","LU0965509101.SGD","LU1162221912.USD","LU1712237335.SGD","LU0471298777.SGD","LU1015430645.USD","LU0672654240.SGD","LU0949170772.SGD","BK4139","LU2023251221.USD","LU0256863811.USD","SG9999015945.SGD","LU2237443382.USD","LU2746668461.USD","LU0345769128.USD","IE00BGHQF631.EUR","LU1720051108.HKD","SG9999001176.SGD","LU1037948541.HKD","LU1061106388.HKD","SG9999015952.SGD","LU1988902786.USD","LU0265550359.USD","GILD","LU0648001328.SGD","LU1023059063.AUD","ABBV","IE00BSNM7G36.USD","BK4585","LU0079474960.USD","IE00B7KXQ091.USD","LU2089284900.SGD","LU1941712348.USD","LU2602419157.SGD","LU0786609619.USD","LU1019632923.USD","SG9999015358.SGD","LU0170899867.USD","LU0708995401.HKD","IE00B894F039.SGD","LU1917777945.USD","LU1487256676.USD","LU1894683348.USD","LU2471134523.USD","LU0203202063.USD","LU0225771236.USD","BK7511","SG9999001176.USD","BK4578","LU2211815571.USD","LU2265009873.SGD","AMGN","LU0432979614.USD","LU1551013425.SGD","LU2360106947.USD","LU0354030511.USD","LU0689472784.USD","BK4559","LU1267930573.SGD","LU0130517989.USD","LU1585245621.USD","IE00B19Z9P08.USD","LU1051770623.HKD","IE00BKPKM643.USD","LU0306806265.USD","LU0499090636.EUR","LU2133065610.SGD","LU1037948897.HKD","LU1116320737.USD","LU1066051498.USD","LU2430703095.HKD","LU0889566641.SGD","LU0225283273.USD","BK7501","LU0211327993.USD","LU0784385170.HKD","LU2089283258.USD","LU0553294199.USD","BK4516","SG9999014880.SGD","IE00B4JS1V06.HKD","LU0128525929.USD","LU0784383803.USD","IE00BLSP4452.SGD","LU2091194634.USD","LU0109391861.USD","IE00BFSS7M15.SGD","LU1170363599.USD","LU2417539215.USD","IE00BKVL7J92.USD","LU1732799900.SGD","LU2106854487.HKD","SG9999011175.SGD","LU2237443465.HKD","LU1066051811.HKD","LU2237443978.SGD","LU0972486137.USD","LU1880407132.USD","LU2087625088.SGD","LU0203347892.USD","IE00BN8TJ469.HKD","LU2361045086.USD","LU1496350171.SGD","LU0158827948.USD","MRK","LU0306807586.USD","LU0098860793.USD","LU0203345920.USD","LU0310800379.SGD","LU1057294990.SGD","LU1496350502.SGD","LU2471134796.USD","LU0511384066.AUD","LU1934455194.USD","SG9999015986.USD","BK4532","LU1069344957.HKD","IE00BJT1NW94.SGD","LU0345777659.USD","NVS","IE00BZ1G4Q59.USD","LU1989771016.USD","LU0784384876.USD","IE00BFXG1179.USD","LU1548497426.USD","SG9999015978.USD","SGXZ51526630.SGD","LU1883839398.USD","LU2279689827.SGD","IE00B3T34201.USD","LU0124676726.USD","LU1934455277.USD","SG9999003800.SGD","LU2552382132.HKD","LU0310800965.SGD","LU0265550946.USD","LU0266013472.USD","LU2112291526.USD","LU1778281490.HKD","LU0795875169.SGD","LU1221951129.SGD","LU0094547139.USD","LU0171293334.USD","LU2746668974.SGD","LU2168564065.EUR","LU1003077747.HKD","LU1127390331.HKD","IE00B1BXHZ80.USD","SGXZ31699556.SGD","LU1718418525.SGD","LU0823434583.USD","IE00B3PB1722.GBP","LU0321505439.SGD","LU0661504455.SGD","LU2456880835.USD","LU0960981461.USD","LU2293690249.USD","LU0096364046.USD","LU1261432733.SGD","LU2114397693.USD","LU1244550494.USD","LU2168564222.USD","LU2168564149.EUR","LU2237443895.HKD","LU0640476718.USD","SG9999018865.SGD","LU0320765489.SGD","SG9999017495.SGD","LU1430594728.SGD","LU0784385840.USD","LU0477156953.USD","LU1032466523.USD","LU1078025761.USD","LU1104425308.USD","LU0345770993.USD","LU2237438978.USD","LU0976567544.SGD","LU1839511570.USD","IE00BDGV0183.EUR","LU0234572021.USD","LU0208291251.USD","LU2552382058.USD","LU0316494557.USD","SG9999002232.USD","SG9999014559.SGD","BK4599","IE00B4R5TH58.HKD","LU2168563687.JPY","IE00BJJMRX11.SGD","LU1868837300.USD","LU0980610538.SGD","LU1093756325.SGD","LU0969580561.USD","LU2491050154.USD","LU2360032135.SGD","SG9999018857.SGD","LU0857590862.USD","LU0985320562.USD","SG9999002224.SGD","IE0004445239.USD","IE00B7SZLL34.SGD","BK4566","LU1481600234.SGD","AZN","LU0211331839.USD"],"gpt_icon":1},{"id":"2604097010","title":"Australian Healthcare Stocks Look Primed for M&A -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604097010","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604097010?lang=en_us&edition=fundamental","pubTime":"2026-01-19 07:49","pubTimestamp":1768780140,"startTime":"0","endTime":"0","summary":"2349 GMT - M&A is a theme to watch among Australian healthcare stocks this year, RBC Capital Markets says. It points to low debt levels in the sector. Most companies covered by RBC are likely to have a leverage ratio of 1.5x or lower, analyst Craig Wong-Pan says. \"We believe the mix of new CEOs, low debt levels and challenging conditions could lead to potential M&A in 2026,\" RBC says. ResMed is likely to keep making small bolt-on acquisitions in respiratory care and adjacent markets, while Ansell could target small or medium-sized deals, RBC says. \"CSL has said it will pivot its R&D activities to focus more on development and it could undertake licensing or partnerships for later stage assets,\" it adds.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLS.AU","BK7124","BK7501","BK4137","BK4585","BK7113","BK7126","HCSG","BK7067","IDX.AU","SHL.AU","BK7007","XBI","XLV","LABU","RHC.AU","CSL.AU","BK7508","LU0029874061.USD","BK7509","BK7511","COH.AU","BK4581","MVF.AU","LU0128526141.USD","BK4588","ANN.AU"],"gpt_icon":0},{"id":"2604709039","title":"CEO Transitions Create Risks for Australian Healthcare Investors -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2604709039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604709039?lang=en_us&edition=fundamental","pubTime":"2026-01-19 07:41","pubTimestamp":1768779660,"startTime":"0","endTime":"0","summary":"2341 GMT - RBC Capital Markets's message to investors in Australian healthcare stocks: Be alert to CEO transition risks. Among companies that have changed leaders in recent months are Ansell, Sonic Healthcare, Integral Diagnostics and Monash IVF. \"The appointments of new CEOs follow long tenure periods under the previous management, and therefore we see possibilities for a combination of strategy resets, asset impairments, and 'kitchen sinking' guidance,\" says analyst Craig Wong-Pan. There could be operational disruptions from the management changes. Also, some managers who missed out on the CEO position could leave, RBC says. \"We also note there have been a number of new CFOs, including at CSL, Ramsay Health Care and Healius,\" it adds. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CSL.AU","BK4581","LABU","BK4585","ANN.AU","BK7508","BK7126","BK7113","BK7067","BK7509","BK7124","BK4588","BK4211","SHL.AU","BK7511","HLS.AU","MVF.AU","RHC.AU","XLV","LU0029874061.USD","ISBC","BK4137","BK7501","IDX.AU","COH.AU","HCSG","LU0128526141.USD","XBI","BK7007"],"gpt_icon":0},{"id":"2603108976","title":"A Look At Carlisle Companies (CSL) Valuation After Recent Share Price Strength Rebuilds Longer Term Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2603108976","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603108976?lang=en_us&edition=fundamental","pubTime":"2026-01-14 19:33","pubTimestamp":1768390389,"startTime":"0","endTime":"0","summary":"Carlisle Companies (CSL) has been drawing attention after recent share price moves, with the stock last closing at $356.42. Investors are weighing this level against the company’s latest financial profile and multi year return record.\nSee our latest analysis for Carlisle Companies.\nThe recent share price strength, including a 6.1% 7 day share price return and an 8.5% year to date share price return, contrasts with a 5.6% decline in 1 year total shareholder return. However, the 5 year total...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/a-look-at-carlisle-companies-csl-valuation-after-recent-shar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/a-look-at-carlisle-companies-csl-valuation-after-recent-shar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0728928796.USD","BK4086","LU1169589451.USD","DCF","LU1169590202.USD","SGXZ23171101.USD","SG9999004303.SGD","BK7067","BK7501","BK7508","CSL","BK7511","CSL.AU"],"gpt_icon":0},{"id":"2603538056","title":"A Look At CSL (ASX:CSL) Valuation As Investors Await Plasma And Vaccine Update In February Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2603538056","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603538056?lang=en_us&edition=fundamental","pubTime":"2026-01-13 23:21","pubTimestamp":1768317685,"startTime":"0","endTime":"0","summary":"CSL (ASX:CSL) is back in focus after an ASX filing confirmed 34,261 employee rights have lapsed. This routine equity update leaves investor attention fixed on February’s half-year results and interim dividend announcement.\nSee our latest analysis for CSL.\nCSL’s share price has been choppy, with a 7 day share price return of 2.99% but a 30 day decline of 5.77%, and a 1 year total shareholder return of 36.8% in the red, suggesting momentum has been fading as investors reassess growth and...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-look-at-csl-asxcsl-valuation-as-investors-await-plasma-and","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/a-look-at-csl-asxcsl-valuation-as-investors-await-plasma-and","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ISBC","BK7511","BK7508","SGXZ23171101.USD","BK4086","LU0728928796.USD","BK4211","CSL","CSL.AU","SG9999004303.SGD","BK7501","LU1169589451.USD","LU1169590202.USD","BK7067"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}